Evidence map›Paper›PMID 39213666›Full record

ArticleJournal of neurosurgery2025

Presentation, surgical outcome, and supplementary motor area syndrome risk of posterior superior frontal gyrus tumors.

Megan M J Bauman, Ignacio Jusue-Torres, Jaclyn J White, Samantha M Bouchal, Andrea R Hsu, Yooree Ha, Andrew D Pumford, Sukwoo Hong, Cecile Riviere-Cazaux, Kimberly Wang and 3 more

Abstract read
In one paragraph

Article in Journal of neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Megan M J Bauman1Mayo Clinic Alix School of Medicine, Rochester, Minnesota; and.
Ignacio Jusue-Torres2Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota.
Jaclyn J White2Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota.
Samantha M Bouchal1Mayo Clinic Alix School of Medicine, Rochester, Minnesota; and.
Andrea R Hsu1Mayo Clinic Alix School of Medicine, Rochester, Minnesota; and.
Yooree Ha1Mayo Clinic Alix School of Medicine, Rochester, Minnesota; and.
Andrew D Pumford1Mayo Clinic Alix School of Medicine, Rochester, Minnesota; and.
Sukwoo Hong2Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota.
Cecile Riviere-Cazaux1Mayo Clinic Alix School of Medicine, Rochester, Minnesota; and.
Kimberly Wang1Mayo Clinic Alix School of Medicine, Rochester, Minnesota; and.
Desmond A Brown2Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota.
Ahmed Helal2Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota.
Ian F Parney2Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota.

Funding

MSTP at Mayo Clinic RochesterT32GM145408 · NIGMS · MAYO CLINIC ROCHESTER · PI SCOTT H KAUFMANN, LISA A SCHIMMENTI · 2023 to 2026
$4.7M
NIGMS NIH HHS T32 GM145408
6 · The paper itself

Abstract

objectiveFollowing resection of posterior superior frontal gyrus (PSFG) tumors, patients can experience supplementary motor area (SMA) syndrome consisting of contralateral hemiapraxia and/or speech apraxia. Given the heterogeneity of PSFG tumors, the authors sought to determine the risk of postoperative deficits and assess predictors of outcomes for all intraparenchymal PSFG tumors undergoing surgery (biopsy or resection), regardless of histology.

methodsThis was a retrospective single-center cohort study of adult PSFG-region tumors undergoing biopsy or resection by a single surgeon.

resultsA total of 106 consecutive patients undergoing 123 procedures (21 biopsies, 102 resections) fulfilled inclusion and exclusion criteria. Anaplastic astrocytomas were the most frequent among resected tumors (39% vs 29%), while glioblastomas were most common among biopsies (38% vs 27%) (p < 0.0001). The biopsy cohort was more likely to have tumor involvement outside the PSFG (90% vs 62%) (p = 0.011), most commonly in the motor cortex (67% vs 31%) (p = 0.005). Seizures were the most common presenting symptom in the resection cohort (p = 0.017), while motor deficits were more common in the biopsy cohort (58% vs 29%) (p < 0.001). Immediate postoperative neurological deficits occurred in 71 cases (58%), but only 3 of the deficits were permanent at 6 months of follow-up (2%). Postoperative SMA syndrome occurred in 48 cases (47%) and was significantly associated with involvement of the motor cortex (p = 0.018) or cingulate gyrus (p = 0.023), which were also significant in multivariate analysis as risk factors for SMA syndrome. However, postoperative SMA syndrome was not significantly associated with overall survival (p = 0.51). There were no perioperative deaths, but corpus callosum involvement (p < 0.001), contrast enhancement (p = 0.003), and glioblastoma pathology (p = 0.038) predicted worse overall survival in patients undergoing resection.

conclusionsNearly half of all patients undergoing resection of PSFG-region tumors experience a postoperative SMA syndrome. Individuals with corpus callosum and/or motor cortex involvement may be at an increased risk of experiencing SMA syndrome. However, these deficits are usually transient, and the risk of permanent new deficits is very low (3%). Preoperative characteristics including corpus callosum involvement and tumor enhancement-in addition to pathology-might serve as predictors of overall survival within this patient population.

Indexed as

Brain NeoplasmsMotor CortexPostoperative ComplicationsAdultAgedApraxiasAstrocytomaCohort StudiesFemaleGlioblastomaHumansMaleMiddle AgedNeurosurgical ProceduresRetrospective StudiesSyndromeneurooncologyoncologyposterior superior frontal gyrusSMA syndromesupplementary motor areatumor surgery

Identifiers

PMID39213666
PMCPMC11801207

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.